Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide
Chad C. Bjorklund(The University of Texas MD Anderson Cancer Center), Robert Z. Orlowski(University of North Carolina at Chapel Hill)
Cited by 129
Related Papers
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
|Journal of Clinical Oncology|2007|645
The role of the ubiquitin-proteasome pathway in apoptosis
|Cell Death and Differentiation|1999|388
Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
|Blood Cancer Journal|2015|216
Evidence That Inhibition of p44/42 Mitogen-activated Protein Kinase Signaling Is a Factor in Proteasome Inhibitor-mediated Apoptosis
|Journal of Biological Chemistry|2002|114